EE+ POEM Archive
Finerenone slightly slows eGFR decline in patients with chronic kidney disease and no diabetes but has no impact on vascular events
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Finerenone Slightly Slows eGFR Decline in Patients With Chronic Kidney Disease and No Diabetes but Has No Impact On Vascular Events." EE+ POEM Archive EE+ POEM Archive, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377727/all/Finerenone_slightly_slows_eGFR_decline_in_patients_with_chronic_kidney_disease_and_no_diabetes_but_has_no_impact_on_vascular_events.
Finerenone slightly slows eGFR decline in patients with chronic kidney disease and no diabetes but has no impact on vascular events. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive EE+ POEM Archive. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377727/all/Finerenone_slightly_slows_eGFR_decline_in_patients_with_chronic_kidney_disease_and_no_diabetes_but_has_no_impact_on_vascular_events. Accessed October 5, 2026.
Finerenone slightly slows eGFR decline in patients with chronic kidney disease and no diabetes but has no impact on vascular events. (2026). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377727/all/Finerenone_slightly_slows_eGFR_decline_in_patients_with_chronic_kidney_disease_and_no_diabetes_but_has_no_impact_on_vascular_events
Finerenone Slightly Slows eGFR Decline in Patients With Chronic Kidney Disease and No Diabetes but Has No Impact On Vascular Events [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive EE+ POEM Archive. John Wiley & Sons; 2026. [cited 2026 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377727/all/Finerenone_slightly_slows_eGFR_decline_in_patients_with_chronic_kidney_disease_and_no_diabetes_but_has_no_impact_on_vascular_events.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Finerenone slightly slows eGFR decline in patients with chronic kidney disease and no diabetes but has no impact on vascular events
ID - 3377727
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377727/all/Finerenone_slightly_slows_eGFR_decline_in_patients_with_chronic_kidney_disease_and_no_diabetes_but_has_no_impact_on_vascular_events
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
